Research Focus

Former Employee. MEDICINE; Clinical Research Associate

Recent additions – View all

1. Phase II study of blinatumomab and concurrent oral tyrosine kinase inhibitor therapy as consolidation and maintenance therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia following chemotherapy-sparing induction

   Meeting Abstract

   Geyer, M. B.; King, A. C.; O'Brien, J. C.; Park, J. H.
   Blood (2020)

   Fulltext@MSK | Save